(Total Views: 506)
Posted On: 08/28/2024 9:24:07 PM
Post# of 154780
A drug used to treat type 2 diabetes is associated with a 35% lower risk of dementia, according to research.
The number of people with dementia globally is expected to nearly triple to 153 million by 2050. The health and social costs linked to dementia already exceed $1tn (£780bn) a year, research shows.
Type 2 diabetes is one of 14 risk factors associated with a greater risk of developing dementia. Other factors are high levels of bad cholesterol, untreated vision loss, hearing impairment, high blood pressure, smoking, obesity and physical inactivity.
Now a large Korean study published in the BMJ has suggested that a medicine used to treat type 2 diabetes, called sodium-glucose cotransporter-2 (SGLT-2) inhibitors, may lower the risk of dementia.
Chemokine (ccr5) respond to this drug?? TIA.
https://www.theguardian.com/society/article/2...tudy-finds
The number of people with dementia globally is expected to nearly triple to 153 million by 2050. The health and social costs linked to dementia already exceed $1tn (£780bn) a year, research shows.
Type 2 diabetes is one of 14 risk factors associated with a greater risk of developing dementia. Other factors are high levels of bad cholesterol, untreated vision loss, hearing impairment, high blood pressure, smoking, obesity and physical inactivity.
Now a large Korean study published in the BMJ has suggested that a medicine used to treat type 2 diabetes, called sodium-glucose cotransporter-2 (SGLT-2) inhibitors, may lower the risk of dementia.
Chemokine (ccr5) respond to this drug?? TIA.
https://www.theguardian.com/society/article/2...tudy-finds
(3)
(0)
